Considerable data have documented the key role the kidney plays in the pathophysiology of hypertension and of the likelihood that alterations in adrenergic response occur in experimental and clinical hypertension. We propose to test the hypothesis that changes in renal adrenergic receptors contribute to pathophysiologic manifestations of hypertension. In our recent work we have demonstrated that we can use radioligand binding techniques to identify and study regulation of the 4 principal subtypes of adrenergic receptors (Alpha1, Alpha2, Beta1, Beta2) in rat renal cortical membranes. In addition, we have developed in vitro autoradiography methods to study adrenergic receptors in kidney slices.
Our aims i n this proposal are to examine changes in receptor expression in vivo by using radioligand binding, in vitro autoradiography, kinetic modelling of binding data, and assessment of biochemical and functional responses. Other studies will examine agonist-mediated uncoupling of receptors and covalent modification in receptors by photoaffinity labelling. We will then use those techniques to assess changes in renal adrenergic receptors in 3 rat models of hypertension: SHR, DOCA-saline, and salt-sensitive Dahl hypertension, each of which may provide unique insights into the role of renal adrenergic receptors in this disease. Our long term goal is to define mechanisms whereby target cells regulate and are regulated by adrenergic receptors. The proposed studies whould provide new insights into mechanisms that operate in vivo to regulate adrenergic receptors and in particular to mechanisms regulating renal receptors in normal and hypertensive animals.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL035847-01
Application #
3350211
Study Section
Cardiovascular and Pulmonary Research B Study Section (CVB)
Project Start
1986-02-01
Project End
1991-01-31
Budget Start
1986-02-01
Budget End
1987-01-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Xing, M; Post, S; Ostrom, R S et al. (1999) Inhibition of phospholipase A2-mediated arachidonic acid release by cyclic AMP defines a negative feedback loop for P2Y receptor activation in Madin-Darby canine kidney D1 cells. J Biol Chem 274:10035-8
Balsinde, J; Balboa, M A; Insel, P A et al. (1999) Regulation and inhibition of phospholipase A2. Annu Rev Pharmacol Toxicol 39:175-89
Xing, M; Firestein, B L; Shen, G H et al. (1997) Dual role of protein kinase C in the regulation of cPLA2-mediated arachidonic acid release by P2U receptors in MDCK-D1 cells: involvement of MAP kinase-dependent and -independent pathways. J Clin Invest 99:805-14
Xing, M; Tao, L; Insel, P A (1997) Role of extracellular signal-regulated kinase and PKC alpha in cytosolic PLA2 activation by bradykinin in MDCK-D1 cells. Am J Physiol 272:C1380-7
Insel, P A; Firestein, B L; Xing, M et al. (1996) P2-purinoceptors utilize multiple signalling pathways in MDCK-D1 cells. J Auton Pharmacol 16:311-3
Xing, M; Insel, P A (1996) Protein kinase C-dependent activation of cytosolic phospholipase A2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells. J Clin Invest 97:1302-10
Ransnas, L A; Jasper, J R; Leiber, D et al. (1992) Beta-adrenergic-receptor-mediated dissociation and membrane release of the Gs protein in S49 lymphoma-cell membranes. Dependence on Mg2+ and GTP. Biochem J 283 ( Pt 2):519-24
Michel, M C; Jager, S; Casto, R et al. (1992) On the role of renal alpha-adrenergic receptors in spontaneously hypertensive rats. Hypertension 19:365-70
Jackson, C A; Michel, M C; Insel, P A (1992) Expression of renal alpha 1-adrenergic receptor subtypes in established hypertension. J Cardiovasc Pharmacol 19:857-62
Klijn, K; Slivka, S R; Bell, K et al. (1991) Renal alpha 1-adrenergic receptor subtypes: MDCK-D1 cells, but not rat cortical membranes possess a single population of receptors. Mol Pharmacol 39:407-13

Showing the most recent 10 out of 34 publications